The tumoricidal properties of photodynamic therapy (PDT) with hypericin (HY
) were evaluated in a highly metastatic adenocarcinoma (DA3(Hi)) and anapla
stic squamous cell carcinoma (SQ2) tumors in vivo. Photosensitization of th
e tumor site with hypericin (HY-PDT) reduced primary tumor development and
significantly prolonged the survival of tumor-bearing (TB) mice. Of these t
wo tumors the squarrous cell carcinoma emerged as more sensitive to HY-PDT
compared with DA3(Hi) adenocarcinoma both in vitro and in vivo. HY-PDT caus
ed extensive tumor necrosis that was followed by local, intratumoral, and s
ystemic inflammatory reactions. Analyses of cytokine mRNA profiles reveal i
ncreases in mRNA levels of expression confined to inflammation-related cyto
kines both within the tumor and also systemically (measured in spleens). Ho
wever, there was no evidence for any HY-PDT-induced antitumoral immune reac
tions. Our results suggest that PDT with hypericin can be considered as a s
upplementary treatment in the management of some invasive and metastatic ca
ncers such as squamous carcinoma and similar tumors.